Investing.com – AbbVie (NYSE:) reported on Friday third quarter that beat analysts’ forecasts and revenue that fell short of expectations.
AbbVie announced earnings per share of $3.66 on revenue of $14.81. Analysts polled by Investing.com anticipated EPS of $3.58 on revenue of $14.93B.
AbbVie shares are up 13% from the beginning of the year and are trading at $153.45 , down-from-52-week-high.
AbbVie shares lost 0.03% in pre-market trade the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar